Hypermetabolism of fat in V1a vasopressin receptor knockout mice

Molecular Endocrinology

Volumn 21, Issue 1, 2007, Pages 247-258

  Hiroyama, Masami ^a   Aoyagi, Toshinori ^a   Fujiwara, Yoko ^a   Birumachi, Junichi ^a   Shigematsu, Yosuke ^d   Kiwaki, Kohji ^c   Tasaki, Ryuji ^b   Endo, Fumio ^c   Tanoue, Akito ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b Chemo Sero Therapeutic Research Institute   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; ACYLCARNITINE; BILE ACID; CARNITINE; CHOLESTEROL; CYCLIC AMP; FAT; FATTY ACID; GLYCEROL; INSULIN; ISOPRENALINE; KETONE BODY; TAURINE; VASOPRESSIN V1A RECEPTOR;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CATABOLISM; CONTROLLED STUDY; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FEEDING; GLYCEROL BLOOD LEVEL; HYPERMETABOLISM; IN VITRO STUDY; LIPID METABOLISM; LIPOLYSIS; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY;

3-HYDROXYBUTYRIC ACID; ACETOACETATES; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CHOLESTEROL; FATTY ACIDS; GLYCEROL; KETONE BODIES; LIPIDS; MICE; MICE, KNOCKOUT; RECEPTORS, VASOPRESSIN; TRIGLYCERIDES; VASOPRESSINS;

EID: 33846020916     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0069     Document Type: Article

References (45)

1. Michell RH, Kirk CJ, Billah MM 1979 Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effect of vasopressin. Biochem Soc Trans 7:861-865
2. Mirsky IA 1968 Metabolic effects of the neurohypophyseal hormones and related polypeptide. In: Berde B, ed. Neurohypophysial hormones and similar polypeptides. Handbook of experimental pharmacology. 23rd ed. Berlin: Springer-Verlag
3. Rofe AM, Williamson DH 1983 Metabolic effects of vasopressin infusion in the starved rat. Biochem J 212:231-239
4. Spruce BA, McCulloch AJ, Burd J, Orskov H, Heaton A, Baylis PH, Alberti KG 1985 The effect of vasopressin infusion on glucose metabolism in man. Clin Endocrinol (Oxf) 22:463-468
5. Dunning BE, Moltz JH, Fawcett CP 1982 The effects of oxytocin and vasopressin on hormone release: comparison of provocative test procedures. Am J Med 56:179-185
6. Yibchok-anun S, Hsu WH 1998 Effects of arginine vasopressin and oxytocin on glucagon release from clonal α-cell line In-R1-G9: involvement of V1b receptors. Life Sci 63:1871-1878
7. Keppens S, De Wulf H 1979 The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis. Biochim Biophys Acta 588:63-69
8. Hems DA 1977 Short-term hormonal control of hepatic carbohydrate and lipid catabolism. FEBS Lett 80:237-245
9. 2+-linked hormones angiotensin II, norepinephrine, and vasopressin stimulate the phosphorylation of distinct substrates in intact hepatocytes. J Biol Chem 257:13135-13143
10. Gewirtz DA, Randolph JK, Goldman ID 1984 Induction of taurocholate release from control of bile salt secretion. Hepatology 4:205-212
11. Egashira N, Tanoue A, Higashihara F, Mishima K, Fukue Y, Takano Y, Tsujimoto G, Iwasaki K, Fujiwara M 2004 V1a Receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze. Neurosci Lett 356:195-198
12. Koshimizu T, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, Takeo S, Okamura H, Tsujimoto G 2006 V1a Vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci USA 103:7807-7812
13. Tebar F, Soley M, Ramirez I 1996 The antilipolytic effects of insulin and epidermal growth factor in rat adipocytes are mediated by different mechanisms. Endocrinology 137:4181-4188
14. Degerman E, Belfrage P, Manganiello VC 1997 Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 272:6823-6826
15. Itoh S 1968 Effect of vasopressin on lipid metabolism. In: Integrative mechanism of neuroendocrine system. Sapporo, Japan: Hokkaido University; 175-197
16. Okuno A, Yamamoto M, Itoh S 1965 Lowering of the body temperature induced by vasopressin. Jpn J Physiol 15:378-387
17. Shido O, Kifune A, Nagasaka T 1984 Baroreflexive suppression of heat production and fall in body temperature following peripheral administration of vasopressin in rats. Jpn J Physiol 34:397-406
18. 2+- dependent mechanism. FASEB J 12:1391-1396
19. DeFronzo RA, Matsuda M, Barret E 1994 Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy. Diabetes Rev 2:209-238
20. McGarry JD 1979 Lilly lecture 1978. New perspectives in the regulation of ketogenesis. Diabetes 28:517-523
21. Ferre P 2004 The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53(Suppl 1):S43-S50
22. Bennett MJ, Rinaldo P, Millington DS, Tanaka K, Yokota I, Coates PM 1991 Medium-chain acyl-CoA dehydrogenase deficiency: postmortem diagnosis in a case of sudden infant death and neonatal diagnosis of an affected sibling. Pediatr Pathol 11:889-895
23. Ding JH, Roe CR, Lafolla AK, Chen YT 1991 Mediumchain acyl-coenzyme A dehydrogenase deficiency and sudden infant death. N Engl J Med 325:61-62
24. Millington D, Chace D 1992 Carnithine and acylcarnithines in metabolic disease diagnosis and management. In: Desiderio DM, ed. Mass spectrometry: clinical and biomedical applications. New York: Plenum Press; 1:299-318
25. Millington DS, Terada N, Chace DH, Chen YT, Ding JH, Kodo N, Roe CR 1992 The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. Prog Clin Biol Res 375:339-354
26. Lafolla AK, Thompson Jr RJ, Roe CR 1994 Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 124:409-415
27. Gregersen N, Winter V, Jensen PK, Holmskov A, Kolvraa S, Andresen BS, Christensen E, Bross P, Lundemose JB, Gregersen M 1995 Prenatal diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in a family with a previous fatal case of sudden unexpected death in childhood. Prenat Diagn 15:82-86
28. Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, Yoon H, Madsen JA, Reyes-Mugica M, Rinaldo P 1998 Retrospective biochemical screening of fatty acid oxidation disorders in postmortem liver of 418 cases of sudden death in the first year of life. J Pediatr 132:924-933
29. Materm D, Strauss AW, Hillman SL, Mayatepek E, Millington DS, Trefz FK 1999 Diagnosis of mitochondrial trifunctional protein deficiency in a blood spot from the newborn screening card by tandem mass spectrometry and DNA analysis. Pediatr Res 46:45-49
30. Rinaldo P, Yoon HR, Yu C, Raymond K, Tiozzo C, Giordano G 1999 Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. Semin Perinatol 23:204-210
31. Harpey JP, Charpentier C, Coude M, Divry P, Paturneau-Jouas M 1987 Sudden infant death syndrome and multiple acyl-coenzyme A dehydrogenase deficiency, ethylmalonic-adipic aciduria, or systemic carnithine deficiency. J Pediatr 110:881-884
32. Harpey JP, Charpentier C, Paturneau-Jouas M 1990 Sudden infant death syndrome and inherited disorders of fatty acid β-oxidation. Biol Neonate 58:70-80
33. Coppack SW, Frayn KN, Humphreys SM, Dhar H, Hockaday TD 1989 Effects of insulin on human adipose tissue metabolism in vivo. Clin Sci (Lond) 77:663-670
34. Ghosh PM, Mikhailova M, Bedolla R, Kreisberg JI 2001 Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptor. AJP Ren Phys 280:F972-F979
35. 2+ signaling during liver regeneration: an interplay stimulating liver growth and bile flow. FASEB J 17:1901-1903
36. Serrière V, Berthon B, Boucherie S, Jacquemin E, Guillon G, Claret M, Tordjmann T 2001 Vasopressin receptor distribution in the liver controls calcium wave propagation and bile flow. FASEB J 15:1484-1486
37. Yokogoshi H, Mochizuki H, Nanami K, Hida Y, Miyachi F, Oda H 1999 Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr 129:1705-1712
38. Bressler R, Katz RI 1965 The role of carnitine in aceto-acetate production and fatty acid synthesis. J Clin Invest 44:840-848
39. Bressler R, Katz RI 1965 The effect of carnitine on the rate of incorporation of precursors into fatty acids. J Biol Chem 240:622-627
40. Abdel-aleem S, Sayed-Ahmed M, Nada MA, Hendrickson SC, St Louis J, Lowe JE 1995 Stimulation of non-oxidative glucose utilization by L-carnitine in isolated myocytes. J Mol Cell Cardiol 27:2465-2472
41. 13C NMR spectroscopy in conscious, freely moving rats. Eur J Biochem 263:287-293
42. Fabian E, Stork A, Kobikova J, Fabianova J 1977 Inhibition of lipolysis by oxytocin and vasopressin. Acta Univ Carol Med Monogr (77 Pt 1):141-145
43. Boston BA, Cone RD 1996 Characterization of melanocortin
44. receptor subtype expression in murine adipose tissues and in 3T3-L1 cell line. Endocrinology 137:2043-2050
45. 2+. FEBS Lett 116:37-40